Monday, April 29, 2024
HomeTagsEpileptic Encephalopathy

Epileptic Encephalopathy

Neurocrine Biosciences Provides Update on Phase 2 Study of NBI-827104 in Pediatric Patients

Neurocrine Biosciences, Inc., a leading neuroscience-focused biopharmaceutical company, today announced that investigational NBI-827104 did not meet its primary endpoint in the Phase 2 STEAMBOAT™...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics